Plaque angiogenesis may be associated with the development of unstable and vulnerable plaques. Vascular endothelial growth factors (VEGFs) are potent angiogenic factors that can affect plaque neovascularization. Our objective was to determine the effect of diabetes on atherosclerosis and on the expression of angiogenesis-related genes in atherosclerotic lesions. Alloxan was used to induce diabetes in male Watanabe heritable hyperlipidemic (WHHL) rabbits that were sacrificed 2 and 6 months after the induction of diabetes. Nondiabetic WHHL rabbits served as controls. Blood glucose (Glc), serum-free fatty acids (FFA), and serum triglyceride levels were significantly higher in diabetic rabbits. Accelerated atherogenesis was observed in the diabetic WHHL rabbits together with increased intramyocellular lipids (IMCL), as determined by 1 H-NMR spectroscopy. Atherosclerotic lesions in the diabetic rabbits had an increased content of macrophages and showed significant increases in immunostainings for vascular endothelial growth factor (VEGF)-A, VEGF-D, VEGF receptor-1, VEGF receptor-2, RAGE, and NF-B. VEGF-A 165 and VEGFR-2 mRNA levels were significantly increased in aortas of the diabetic rabbits, where a trend toward increased plaque vascularization was also observed. These results suggest that diabetes accelerates atherogenesis, up-regulates VEGF-A,
Metabolic abnormalities that characterize diabetes, particularly hyperglycemia, insulin resistance, increased levels of free fatty acids (FFA), and dyslipidemia (2, 3) , provoke cellular and molecular mechanisms that can alter the function and structure of blood vessels and have discrete effects on the initiation and progression of atherosclerotic lesions. Depending on the site of lesions, fatal events such as a myocardial infarction or a cerebral stroke can occur. Plaque angiogenesis may be associated with increased atherogenesis and unstable vulnerable plaques (4, 5) . Vascular endothelial growth factors (VEGFs) are potent angiogenic factors that can affect plaque neovascularization. It is therefore important to determine the effects of diabetes on VEGF expression and plaque angiogenesis in atherosclerotic lesions.
In 1980, Watanabe et al. reported the breeding of Watanabe heritable hyperlipidemic (WHHL) rabbits (6) , which have markedly elevated levels of serum lipids. WHHL rabbits have a defective LDL receptor (LDLr) due to a spontaneous 4 amino acid deletion in the cysteine-rich ligand binding domain of the receptor (7) in exon-4 of the LDLr gene. WHHL rabbits are also characterized by hyperinsulinemia, both in the fasting state and during an intravenous (i.v.) Glc tolerance test, but they have a relatively normal Glc tolerance (8) . Even though WHHL rabbits have been used extensively in hyperlipidemia and atherosclerosis research, to the best of our knowledge no data are available from well-characterized diabetes models in WHHL rabbits. Here we report induction of diabetes in WHHL rabbits using alloxan injection. This model was then used to characterize factors associated with accelerated atherosclerosis and plaque neovascularization.
MATERIALS AND METHODS
Diabetes was induced in male WHHL rabbits (nϭ15, between 6 and 10 months of age) by a single i.v. injection of alloxan (Sigma Aldrich, St. Louis, MO, USA), 100 mg/kg dissolved in 10 ml of 0.9% NaCl. Blood Glc was monitored before alloxan injection, then every 2 h for 8 h after the alloxan injection. Blood Glc levels were measured every morning using a standard Glucometer (ELITA XL-Bayer). To prevent life-threatening hyperglycemia, diabetic rabbits were treated with injections of Ultratard Insulin (1-2 U/kg, Novo Nordisk) whenever the morning blood Glc level was Ͼ18 mmol/l. The majority of the rabbits (nϭ13) developed severe hyperglycemia within 24 -48 h of alloxan injection. Rabbits that died (nϭ3) of diabetic ketoacidosis and those that remained euglycemic after alloxan injection (nϭ2) or became euglycemic 3 months after the injection (nϭ1) were excluded from the study. All deaths occurred in the first week after induction of diabetes. Diabetic WHHL rabbits (nϭ9) and nondiabetic WHHL controls (nϭ9) were used for this study. Diabetic and control animals were divided into two subgroups. Animals from the diabetic (nϭ6) and the control subgroups (nϭ5) were sacrificed 2 months after the induction of diabetes. A second group of diabetic rabbits (nϭ3) and controls (nϭ4) was sacrificed 6 months after the induction of diabetes. All rabbits received standard chow and water ad libitum. Experiments were approved by the Experimental Animal Committee, University of Kuopio, Finland.
Oral Glc tolerance test (OGTT)
Rabbits were fasted overnight and a fasting blood Glc level was measured. Thereafter, rabbits were given orally 1.2 g of Glc/kg body wt. Blood Glc levels were measured at 15, 30, 60, 90, and 120 min using a glucometer (ELITA XL-Bayer).
Serum lipids
Arterial blood was collected at baseline and before sacrificing the animals. Total serum cholesterol and triglyceride levels were measured by standard enzymatic procedures using Ecoline ® reagent kits (E. Merck, Darmstadt, Germany). FFA were measured by an enzymatic colorimetric method (Wako NEFA C test kit; Wako Chemicals GmbH, Neuss, Germany)
H-NMR spectroscopy
Two months after the induction of diabetes, nuclear magnetic resonance ( 1 H-NMR) spectrum was obtained from the biceps femoris muscles of the diabetic rabbits (nϭ6) and nondiabetic controls (nϭ5). MRS was performed with a horizontal bore 4.7 T magnet equipped with actively shielded field gradients interfaced to a Varian UNITY INOVA console. A quadrature surface coil was used both as a transmitter and a receiver. Gradient echo images were acquired to place the voxel to the muscle. For metabolite analysis, LASER method incorporating water suppression was used (9) (repetition time TRϭ6s, echo time TEϭ34ms and number of scans NSϭ128). Non-water-suppressed spectra were obtained similarly (NSϭ8) to provide a reference. For measurements, the major axis of the muscle was aligned parallel to the magnetic field in order to prevent differences in orientation-dependent effects between animals. Spectral analysis was performed in the time domain using jMRUI software (http://carbon.uab.es/mrui). Metabolite concentrations were calculated based on the water content. Since relaxation times of the signals from lipids and creatine are intraand interindividually constant and the applied echo times were short; results were not corrected for relaxation effects (10).
Cell culture, RNA isolation, and cDNA synthesis Rabbit aortic smooth muscle cells (RAASMCs) were cultured in 100 mm plates in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% FBS (Life Technologies, Inc., Grand Island, NY, USA) and 100 U/ml streptomycin/ ampicillin at 37°C in a humidified atmosphere of 5% CO 2 until 60% to 70% confluent. Total RNA was extracted from RAASMC using RNeasy kit (Qiagen, Valencia, CA, USA). Genomic DNA was digested by thorough treatment with DNase I (Qiagen). Reverse transcription was done using random hexamers with "You prime First strand cDNA synthesis kit" ® (Amersham Biosciences, Freiburg, Germany).
Quantitative RT-polymerase chain reaction (RT-PCR)
Aortic samples from 2 month diabetic and control groups were snap frozen in liquid nitrogen for RNA extraction. Total RNA was extracted from the segments using Trizol reagent (Gibco BRL 
Histology
After sacrificing the animals, the lower thoracic aorta and upper abdominal aorta were dissected and immersion fixed in 4% paraformaldehyde/15% sucrose (pH 7.4) overnight, processed, and embedded in paraffin for further histological evaluation (11) . To determine the effect of diabetes on atherosclerosis, hematoxylin-eosin and immunohistochemical stainings were performed on 6 m-thin paraffin sections from aortas. Immunohistochemistry on paraffin sections was done with the avidinbiotin-HRP method and 3,3Ј-diaminobenzidine was used as a substrate (Vector Laboratories, Burlingame CA, USA 
Morphometry and image analysis
Morphometry and image analysis were done using AnalySIS (Soft Imaging Systems, Munster, Germany) software with Olympus AX70 microscope (Olympus Optical, Japan). The specimens were analyzed by an expert operator (S.B.) in a blinded manner. Total area of atherosclerotic plaques was measured from five standardized sections (stained with hematoxylin-eosin) of each animal using the imaging software and the mean value of the affected area is reported (13) . The total number of cluster of differentiation (CD)-31-positive capillaries in the intima was counted and data were expressed as a number of capillaries/mm 2 . Semiquantitative immunohistochemical analysis was performed by the image processing software that was programmed to select immunostained or immunofluorescent areas based on preset thresholds (14) . The positively stained areas were then calculated as percentages of the total intimal cross-sectional area (12) .
Statistical analysis
Data were tested for homogeneity of variance by the Levene's test. Logarithmic transformations were performed to correct unequal variance in the data. Two-tailed unpaired t test was used for the comparison of two variables. Response to diabetes and duration was determined by 2-way ANOVA, and Benferroni's post hoc test was used to compare subgroups. P Յ 0.05 was considered statistically significant. Data are expressed as mean Ϯ sd. Statistical calculations were performed using GraphPad Prism version 4.00 for Windows, (GraphPad Software, San Diego California, USA).
RESULTS

Induction of diabetes
Mean blood Glc in the diabetic WHHL rabbits was significantly higher (PϽ0.001) in the 2 month and 6 month diabetic subgroups compared with nondiabetic controls (Fig. 1A) . OGTT showed high fasting blood Glc levels (17.96Ϯ5.14 mmol/l) in the diabetic groups, with high levels of blood Glc (24.98Ϯ5.16 mmol/l) persisting 2 h after the initial Glc load. In the control group the fasting blood Glc levels were in the normal range (4.86Ϯ0.30 mmol/l), and the blood Glc level returned back to normal (5.2Ϯ0.20 mmol/l) 2 h after the initial Glc load (Fig. 1B) . Mean daily morning blood Glc was significantly higher (PϽ0.001) in 2 and 6 month diabetic WHHL rabbits (black bars) than in control rabbits (gray bars). A) High fasting blood Glc levels were observed in diabetic animals during oral Glc tolerance test (OGTT) and high levels of blood Glc persisted for 2 h after the initial Glc load. In the control group, fasting blood Glc levels remained in the normal range and blood Glc values returned to normal 2 h after the initial Glc load (B). Serum cholesterol levels tended to be higher in the diabetic WHHL rabbits than in controls, but the differences were not statistically significant (C). Serum triglyceride levels were significantly higher in the 2 and 6 month diabetic subgroups than in the control rabbits (PϽ0.01) (D). 
Serum lipids
Serum cholesterol levels in the diabetic rabbits tended to be higher at the 2 and 6 month time points, but the differences did not reach statistical significance (Fig.  1C) . Serum triglyceride levels were significantly increased (PϽ0.001) in the 2 month and 6 month diabetic subgroups (Fig. 1D) .
Intramyocellular lipids and serum-free fatty acids
Increased delivery of FFA to muscles contributes to insulin resistance (15) . Two months after the induction of diabetes, a significant increase (PϽ0.05) was found in serum FFA levels of the diabetic rabbits (Fig 2B) . This leads to the accumulation of triglycerides in skeletal muscle. Proton magnetic resonance spectroscopy ( 1 H-NMR) was used to assess intramyocellular lipids (16) (IMCL). We observed a significant increase (PϽ0.05) in the IMCL levels in the diabetic rabbits ( Fig. 2A) .
Enhanced atherogenesis in diabetic rabbits
Atherosclerosis was significantly increased in the 2 month (PϽ0.01) and 6 month (PϽ0.001) diabetic subgroups (Fig 2C) . Image analysis showed a significant (PϽ0.001) increase in the immunostained area positive for macrophages in the diabetic rabbits at 6 months (Fig.  3A) . Macrophages and foam cells were present in the atherosclerotic lesions of both the diabetic and control rabbits. Macrophage infiltration was most prominent in the subendothelial region (Fig. 4A-D) and in the shoulder regions of the plaques. Large numbers of smooth muscle cells were seen in the atherosclerotic lesions in both groups (Fig. 3B, Fig. 4E-H ).
Increased RAGE expression in diabetic plaques
A strong RAGE immunoreactivity was seen in atherosclerotic plaques of the diabetic animals. There was a significant increase in RAGE staining in both the 2 and the 6 month diabetic subgroups. RAGE localized predominantly in the endothelial cells, subendothelial region, macrophages, and foam cells (Fig. 3C, Fig. 4I-L) .
Increased presence of NF-B in diabetic atherosclerotic lesions
Immunohistochemical staining for NF-B p65 was significantly higher in both the 2 and 6 month diabetic rabbits (Fig. 3D) . NF-B staining was most prominent in macrophages, but positive immunostaining was also observed in some endothelial cells and smooth muscle cells ( Fig. 4M-P) .
Angiogenic growth factors and angiogenesis
Real-time quantitative RT-PCR from aortas showed that VEGF-A165 mRNA expression was significantly increased in the diabetic rabbits. The VEGF-A121 mRNA expression levels were comparable in the aortas of the diabetic and the control animals (Fig. 5A) .
VEGF-A immunostaining was significantly increased both in the 2 month and 6 month diabetic subgroups. VEGF-A immunostaining was observed in some lesionmacrophages and smooth muscle cells. VEGF-A staining was also observed in the subendothelial region (Fig.  3E, Fig. 6A-D) .
VEGF-D immunostaining tended to be increased in the 2 month diabetic subgroup, but the difference with Figure 2 . Two months after induction of diabetes, IMCL levels were significantly increased in diabetic rabbits (PϽ0.05) (A). Serum FFA levels were also significantly increased (PϽ0.05) in diabetic animals (B). The mean area of atherosclerotic lesions in aorta was significantly larger in diabetic rabbits compared with controls (PϽ0.001) (C).
the controls was not significant. On the other hand, a significant increase was found in the 6 month diabetic subgroup (Fig. 3F) . VEGF-D was detected in macrophages, smooth muscle cells, and endothelial cells. Positive VEGF-D staining was also seen in the adjacent extracellular area (Fig. 6E-H) .
RT-PCR and immunohistochemistry confirmed VEGFR-1 and VEGFR-2 expression in aortic samples. VEGFR-1 immunostainings were detected in the endothelial cells, macrophages, and SMCs (Fig. 6I-L) . VEGFR-1 immunostainings were significantly increased in the atherosclerotic lesions of the 6 month diabetic rabbits (Fig. 3H) . VEGFR-2 mRNA levels were significantly increased in aortic samples of diabetic rabbits (Fig. 5B) . VEGFR-2 immunostaining was detected in SMCs and also in some endothelial cells ( Fig. 6M-P) . VEGFR-2 staining in the atherosclerotic plaques of the 2 month diabetic subgroup was not significantly different, but in the 6 month diabetic rabbits a significant increase was found (Fig. 3G) . Expression of VEGFR-1 and VEGFR-2 in SMCs was confirmed by RT-PCR of the cultured RAASMC (Fig. 5F ).
Positive CD-31 immunostaining was localized in the endothelium (Fig. 6Q-T) . Some medium-sized blood vessels were also seen in the aortic wall in the 6 month diabetic subgroup (Fig. 6U) . Positive VEGF-D and VEGF-A stainings were observed in the walls of these vessels (data not shown). The number of vessels in the atherosclerotic lesions of the diabetic rabbits tended to be higher, but the difference with the controls was not significant (Fig. 3I) . No evidence of plaque rupture or thrombosis was seen in the lesions.
DISCUSSION
In diabetes, excess FFAs, insulin resistance, and hyperglycemia generate adverse metabolic events in Figure 3 . Immunohistochemical analysis of atherosclerotic lesions in diabetic rabbits. A) RAM-11 immunostaining for macrophages was significantly increased in the 6 month subgroup. B) HHF-35 immunostaining for smooth muscle cells in diabetic and control rabbits was similar. C) Areas of RAGE and D) NF-B p65 immunostainings were significantly increased in diabetic rabbits. E) VEGF-A staining was significantly increased in diabetic rabbits at both time points whereas F) VEGF-D staining was only increased in the 6 month time point. G) A significant increase in VEGFR-2 and H) VEGFR-1 immunostaining was present at the 6 month time point in diabetic rabbits. I) The number of capillaries in the atherosclerotic lesions of the diabetic rabbits tended to be increased compared with the controls, but the difference was not statistically significant. *P Ͻ 0.05; **P Ͻ 0.01; ***P Ͻ 0.001. endothelial cells that result in endothelial dysfunction, augmented vasoconstriction, inflammation, and thrombosis (17) (18) . Elevated triglyceride and total cholesterol levels are also known to increase the risk of cardiovascular diseases in diabetes (19) . An animal model for diabetic macrovascular disease should therefore have increased FFA, insulin resistance, hyperglycemia, and dyslipidemia.
Insulin resistance is one factor contributing to the development of diabetic atherosclerotic disease (2, 17) . Increased flux of FFAs into the skeletal muscle or a decrease in intracellular metabolism of FFAs leads to insulin resistance in both type-1 and type-2 diabetes (20, 21) . WHHL rabbits have a moderate insulin resistance (8) , and our studies showed that IMCL levels in control WHHL rabbits are significantly higher than in New Zealand white rabbits (unpublished data). In the present study the IMCL levels were significantly increased in diabetic WHHL rabbits as compared with the nondiabetic controls, indicating an accumulation of triglycerides in skeletal muscle and an increase in insulin resistance after induction of diabetes.
Increased FFA delivery to liver also results in increased production of triglyceride-rich VLDL from the liver, which contributes to the development of hypertriglyceridemia in diabetes (22) . In the present study, serum triglyceride levels were significantly increased in the diabetic rabbits. Hypertriglyceridemia is an important feature of diabetic dyslipidemia (23). Thus, induc- Representative examples of atherosclerotic lesions in diabetic and control rabbits; A-D) Macrophages (RAM-11 immunostaining) were seen mainly in the subendothelial region of the A) 2 month and B) 6 month control rabbits. Increased immunostaining was seen in the atherosclerotic lesions of the C) 2 month and D) 6 month diabetic rabbits. E-H) Large numbers of SMC (HHF-35 immunostaining) were present in the atherosclerotic lesions of the E) 2 month and F) 6 month control rabbits and in the atherosclerotic lesions of the G) 2 month and H) 6 month diabetic rabbits. I-L) Only some RAGE immunostaining was seen in atherosclerotic plaques of the I) 2 month and J) 6 month control rabbits whereas a marked increase in RAGE immunostaining was observed in the atherosclerotic lesion of the K) 2 month and L) 6 month diabetic rabbits. M-P) In NF-B p65 immunostaining, some positive cells were seen in the M) 2 month and N) 6 month control rabbits whereas O) a moderate increase in the NF-B p65 staining was seen in the 2 month diabetic group. P) An intense NF-B p65 staining was seen in the atherosclerotic lesions of the 6 month diabetic rabbits. Arrows indicate a positive signal (scale bar 100 m).
tion of diabetes in WHHL rabbits produced an animal model that had increased FFA, insulin resistance, hyperglycemia, and dyslipidemia.
We used this animal model to evaluate the effects of diabetes on atherosclerosis and plaque angiogenesis. Diabetes in WHHL rabbits accelerated atherogenesis. Macrophages were more prevalent together with an increase in NF-B immunostaining in the atherosclerotic lesions of the diabetic rabbits. These findings suggest that diabetes augments inflammatory reactions in atherosclerotic lesions.
RAGE is a multiligand member of the immunoglobulin superfamily of the cell surface molecules. It has been hypothesized that the ligand-RAGE axis amplifies vascular stress and accelerates atherosclerosis (24) . Thus, RAGE, and NF-B overexpression in atherosclerotic lesions is associated with enhanced inflammatory reactions in the vessel wall (25). It has been reported that VEGF-A enhances progression of atherosclerotic plaques (26) . VEGF-A and VEGF-D, a new member of the VEGF family, are expressed in medial smooth muscle cells and in macrophages of human atherosclerotic lesions (27) , but the effect of diabetes on the expression of VEGFs in atherosclerotic arteries is not well documented. The results of this study support the findings that have demonstrated the expression of VEGF receptors in vascular smooth muscle cells (28) . SMC proliferation I-L) . Only a few VEGFR-1-positive cells were seen in endothelium and in the atherosclerotic lesions at I) 2 month and J) 6 month control rabbits. Increased VEGFR-1 staining was seen in the atherosclerotic lesions of the K) 2 month and L) 6 month diabetic rabbits. VEGFR-2 staining in atherosclerotic lesions (M-P). Only a few VEGFR-2-positive cells were seen in the M) 2 month and N) 6 month control rabbits. O) Increased VEGFR-2 staining was seen in the atherosclerotic lesions of the 2 month and P) 6 month diabetic rabbits. CD-31 staining for endothelium was used as a marker for blood vessels in the atherosclerotic plaques (Q-U). Besides the endothelium, only a few CD-31-positive structures were seen in the Q) 2 month and R) 6 month control rabbits whereas increased immunostaining was seen in the S) 2 month and T) 6 month diabetic rabbits. U) Some larger blood vessels were also seen in the shoulder region of the plaques in the 6 month diabetic rabbits. Arrows indicate a positive signal (scale bar 100 m).
and migration in response to VEGFs seen in various vascular pathologies presumably are at least to some extent modulated through these receptors (28, 29) . VEGF-A 165 and VEGFR-2 expression was up-regulated in the aortas of diabetic rabbits. VEGF-A, VEGF-D, VEGFR-1, and VEGFR-2 immunostainings were also increased in the atherosclerotic plaques of the diabetic rabbits. The presence of VEGFs in macrophages and in the macrophage-rich subendothelial region of the atherosclerotic plaques in the diabetic rabbits was observed. This indicates that macrophages, RAGE, and NF-B may modulate the presence of VEGFs in atherosclerotic lesions. Induction of VEGF-A and VEGF-D through a pathway involving RAGE and NF-B/activating protein-1 (30) could explain the increased expression of VEGFs in the atherosclerotic lesions of the diabetic rabbits.
This study shows that diabetes increases inflammatory responses and expression of VEGF-A, VEGF-D, VEGF receptor-1, and VEGF receptor-2 in atherosclerotic lesions. To the best of our knowledge this is the first study reporting a diabetic model in WHHL rabbits and the presence of small vessels in their atherosclerotic plaques. Diabetic WHHL rabbits will be a useful model to study the pathogenesis of diabetic macroangiopathy. 
SPECIFIC AIMS
The objectives of this study were to 1) to develop a diabetic hyperlipidemic animal model that would allow studies of the combined effects of these risk factors on atherogenesis and 2) investigate the effects of these risk factors on the expression of vascular endothelial growth factor (VEGF)-A, VEGF-D, VEGFR-1, VEGFR-2, and angiogenesis in atherosclerotic lesions.
PRINCIPAL FINDINGS
Accelerated atherogenesis in diabetic rabbits
Alloxan was used to induce diabetes in male Watanabe heritable hyperlipidemic (WHHL) rabbits that were sacrificed 2 and 6 months after the induction of diabetes. Nondiabetic WHHL rabbits served as controls. Blood glucose (Glc), serum-free fatty acids (FFA), and serum triglyceride levels were significantly higher in diabetic rabbits. A significant increase (PϽ0.05) in intramyocellular lipids (IMCL), as determined by 1 H-NMR spectroscopy, was observed in the diabetic rabbits. Atherosclerosis was significantly increased in the 2 month (PϽ0.01) and 6 month (PϽ0.001) diabetic groups (see online manuscript) along with a significant (PϽ0.001) increase in the immunostained area positive for macrophages in the diabetic rabbits at 6 months (Fig. 1A) .
Increased RAGE and NF-B p65 expression in atherosclerotic lesions of diabetic rabbits
There was a significant increase in RAGE staining in both the 2 and the 6 month diabetic rabbits. RAGE localized predominantly in the endothelial cells, subendothelial region, macrophages, and foam cells (Fig.   1C ). Immunohistochemical staining for NF-B p65 was significantly higher in both the 2 and the 6 month diabetic rabbits (Fig. 1D) . NF-B p65 staining was most prominent in macrophages, but positive immunostaining was also observed in some endothelial cells and smooth muscle cells.
Angiogenic growth factors and angiogenesis in atherosclerotic plaques
Real-time quantitative RT-polymerase chain reaction (RT-PCR) from aortas showed that VEGF-A 165 mRNA expression was significantly increased (PϽ0.05) in the diabetic rabbits (see online manuscript). VEGF-A 121 mRNA expression levels were comparable in the aortas of diabetic and control animals. VEGF-A immunostaining was significantly increased in both the 2 and the 6 month diabetic subgroups (Fig. 1E) . VEGF-A immunostaining was localized mostly in lesion macrophages and smooth muscle cells.
VEGF-D immunostaining tended to be increased in the 2 month diabetic group, but the difference with the controls was not significant. In the 6 month diabetic group, however, a significant increase was found (Fig.  1F) . VEGF-D was detected in macrophages, smooth muscle cells, and endothelial cells.
VEGFR-1 immunostaining was seen in endothelial cells, macrophages, and some smooth muscle cells VEGFR-2 immunostaining was detected in smooth muscle cells and in some endothelial cells. VEGFR-1 and VEGFR-2 stainings in the atherosclerotic plaques were significantly increased in the 6 month diabetic rabbits (Fig. 1G, H) . VEGFR-2 mRNA levels were also significantly increased in the aortas of the diabetic rabbits (see online manuscript).
Positive cluster of differentiation-31 (CD-31) immunostaining was localized in the endothelium. Some medium-sized blood vessels were also seen in the aortic wall in the 6 month diabetic rabbits. The number of vessels in the atherosclerotic lesions of the diabetic rabbits tended to be higher than the controls, but the difference did not reach statistical significance (Fig 1I) .
CONCLUSIONS AND SIGNIFICANCE
Alloxan-induced diabetes in WHHL rabbits significantly increased serum cholesterol, triglyceride, and FFA levels. There was also a significant increase in IMCL content and atherosclerosis in these animals. Thus, induction of diabetes in WHHL rabbits produced an animal model that had increased FFA, insulin resistance, hyperglycemia, and dyslipidemia. We used this animal model to evaluate the effects of diabetes on atherogenesis and plaque angiogenesis. This study demonstrated a significant increase in the presence of VEGF-A, VEGF-D, VEGF receptor-1, and VEGF receptor-2 and a trend toward increased vascularization in the atherosclerotic lesions of the diabetic WHHL rabbits. The results also show a significant increase in VEGF-A 165 but not VEGF-A 121 mRNA expression in the diabetic rabbits. This suggests that diabetes has a selective effect on the expression of different VEGF-A isoforms. An increased presence of NF-B p65 and RAGE was also found in diabetic atherosclerotic lesions. This indicates that diabetes increases proinflammatory responses in the atherosclerotic lesions. Induction of Figure 1 . Immunohistochemical analysis of atherosclerotic lesions in diabetic rabbits. A) RAM-11 immunostaining for macrophages was significantly increased in the 6 month subgroup. B) HHF-35 immunostaining for smooth muscle cells in diabetic and control rabbits was similar. C) Areas of RAGE and D) NF-B p65 immunostainings were significantly increased in diabetic rabbits. E) VEGF-A staining was significantly increased in diabetic rabbits at both time points whereas F) VEGF-D staining was increased only at the 6 month time point. G) A significant increase in VEGFR-2 and (H) VEGFR-1 immunostaining was present at the 6 month time point in diabetic rabbits. I) The number of capillaries in the atherosclerotic lesions of the diabetic rabbits tended to be increased compared with controls, but the difference was not statistically significant. *P Ͻ 0.05; **P Ͻ 0.01; ***P Ͻ 0.001.
VEGF-A and VEGF-D through a pathway involving RAGE and NF-B/activating protein-1 could explain the increased expression of VEGFs in the atherosclerotic lesions of the diabetic rabbits. In conclusion, we generated a model of diabetic macrovascular disease.
Our results suggest that diabetes accelerates atherogenesis, up-regulates VEGF-A, VEGF-D, VEGF receptor-1 expression and VEGF receptor-2 expression and increases NF-B, RAGE, and proinflammatory responses in atherosclerotic leisons. 
